Pharma Focus Asia
KP - Sustainable Packaging Solutions

Amgen Opens New Biomanufacturing Plant in North Carolina


Amgen announces plans for the construction of new manufacturing facility. The new plant will be dedicated in manufacturing medicines to treat serious illnesses such as cancer and heart disease.


The new manufacturing facility will be added to the existing robust biomanufacturing ecosystem. It ensures to produce wide range of medicines to patients by making use of new technologies to maximize efficiency and quality.

The new facility will meet the exacting environmental standards, reduces water usage by 40 percent and waste by 75 percent and becoming carbon neutrality by 2027. Moreover, the plant evolves as a major hub for biopharmaceutical innovation.

Currently it has manufacturing facilities in California, Ireland, Netherlands, Ohio, Puerto Rico, Rhode Island and Singapore.

The construction of the new facility is expected to be completed and fully operational by 2025.

The site already consists of 24,000 employees worldwide and the new facility is expected to add an additional 350 high-quality new jobs.


TypeNew Construction
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?